MENU
+Compare
EXAS
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$45.60
Change
+$0.61 (+1.36%)
Capitalization
8.63B

EXAS Exact Sciences Corp Forecast, Technical & Fundamental Analysis

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally... Show more

Industry: #Biotechnology
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EXAS with price predictions
Aug 15, 2025

EXAS in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 07, 2025

EXAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where EXAS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EXAS's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where EXAS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EXAS just turned positive on August 15, 2025. Looking at past instances where EXAS's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXAS advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EXAS as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EXAS moved below its 50-day moving average on July 15, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXAS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EXAS entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.497) is normal, around the industry mean (9.935). P/E Ratio (0.000) is within average values for comparable stocks, (140.379). EXAS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.787). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.892) is also within normal values, averaging (8.653).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EXAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EXAS is expected to report earnings to rise 74.00% to -1 cents per share on October 29

Exact Sciences Corp EXAS Stock Earnings Reports
Q3'25
Est.
$-0.02
Q2'25
Beat
by $0.12
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.27
Q3'24
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of 0 cents, beating the estimate of -12 cents. With 3.89M shares outstanding, the current market capitalization sits at 8.63B.
A.I. Advisor
published General Information

General Information

a developer of proprietary technologies for the detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5505 Endeavor Lane
Phone
+1 608 284-5700
Employees
6600
Web
https://www.exactsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLV73.29-0.18
-0.25%
American Century Foc Lrg Cp Val ETF
ICAP27.09-0.08
-0.28%
Infrastructure Capital Equity Income ETF
TLTW22.71-0.11
-0.48%
iShares 20+ Year Trs Bd Buywrt Stgy ETF
BLKC25.39-0.15
-0.60%
Invesco Aln Glxy Blkh Usr&Dctrzd Cmr ETF
ETHU157.51-11.86
-7.00%
2x Ether ETF

EXAS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with ILMN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
+1.36%
ILMN - EXAS
36%
Loosely correlated
+0.02%
RVTY - EXAS
34%
Loosely correlated
+1.49%
A - EXAS
33%
Loosely correlated
+0.28%
XRAY - EXAS
33%
Poorly correlated
-0.14%
SNN - EXAS
32%
Poorly correlated
-1.15%
More